Squarepoint Ops LLC Ventyx Biosciences, Inc. Transaction History
Squarepoint Ops LLC
- $99.2 Billion
- Q4 2024
A detailed history of Squarepoint Ops LLC transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 62,990 shares of VTYX stock, worth $83,146. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62,990
Previous 71,810
12.28%
Holding current value
$83,146
Previous $156,000
12.18%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding VTYX
# of Institutions
134Shares Held
55.2MCall Options Held
81.4KPut Options Held
148K-
Black Rock Inc. New York, NY4.77MShares$6.3 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.48MShares$5.92 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.27MShares$5.64 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY4.05MShares$5.34 Million3.31% of portfolio
-
Ubs Group Ag3.78MShares$4.99 Million0.0% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $74.6M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...